Piperidine derivatives and their use as muscarinic receptor modulators
US8119661B2 · kind B2 · utility
11Cited by
7References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 8, 2008 |
| Grant date | Feb 21, 2012 |
| Priority date | — |
| Expiry date | Jun 18, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of Formula I, or pharmaceutically acceptable salts thereof:wherein R2, R3, X, m and n are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.